Aids, tecnologia e acesso sustentável a medicamentos: a incorporação dos anti-retrovirais no Sistema Único de Saúde / Aids, technology and sustainable access to medicine: the incorporation of antiretroviral drugs in the Single Health System

AUTOR(ES)
DATA DE PUBLICAÇÃO

2008

RESUMO

This thesis brings, in addition to concepts about the incorporation of technologies in health, an approach to the Brazilian institutional regulation, together with the description of the history and the functioning of medicines for the treatment of aids. In the second part of the work, based on a series of interviews, the courses and processes of the incorporation of antiretroviral drugs in Brazil are described and analyzed, just like the public policy in which they are inserted and the intermediation of the government program in the introduction of this technology. Also, we identify the institutions, groups or corporations - pharmaceutical companies, Surgeon General, doctors, people who live with HIV and aids and Judiciary Power -, who work in three courses of the incorporation of the technology in question. In the scientific course, there is the validation of the technology through research with human beings and the preparation of clinical guidelines. The regulatory phase of the technology, with its official register and its prescriptive stage, when the promotion and marketing of the pharmaceutical companies also occur, and also the legal actions that make the government provide the drugs, characterize the transition course. As for the mercantile course, it contains the aspects related to demand, supply, production, price, purchase and sale of antiretroviral drugs. The study shows the absence of an integrated, systemic regulatory action of the State on all the courses of the incorporation of the antiretroviral drugs. It also points out important aspects for better understanding the introduction of new technologies in the Unified Health System, whereas it suggests the need of new strategies in order to guarantee the sustainability of the Brazilian policy of universal access to the treatment of aids.

ASSUNTO(S)

anti-hiv agents single health program. health policy síndrome da imunodeficiência adquirida acquired immunodeficiency syndrome agentes anti-hiv política de saúde biomedical technology tecnologia biomédica sistema Único de saúde anti-retrovirais anti-retroviral agents

ACESSO AO ARTIGO

Documentos Relacionados